Questions? 800.442.1161
SOCIALIZE WITH LEGALVIEW.COM
Between 1940 and 1979, it is estimated that 27.5 million people were occupationally exposed to asbestos in the United States. As a result, it is increasingly important that doctors and patients be able to recognize the symptoms of mesothelioma, a form of lung cancer that is nearly always associated with exposure to asbestos. What can make mesothelioma so dangerous is ... read more →
Yasmin, Yaz and the generic Ocella birth control pills have been linked to potentially fatal health issues including heart attacks, strokes, pulmonary embolism and gallbladder disease. One of the main ingredients, drospirenone, may be responsible for the increased cardiovascular risk, as it has been linked to an increase in potassium levels in the blood. Although Bayer has upheld the safety of the drugs, several Yasmin lawsuits have been filed nationwide.
Fixodent, a leading denture cream, has been linked to several reports claiming the adhesive is responsible for zinc poisoning, which can result in liver problems, kidney failure, neurological problems and other serious side effects. Some reports have indicated that the side effects can be premanent.
PROTECT YOURSELF AND THE ONES YOU LOVE BY STAYING INFORMED ON BREAKING LEGAL NEWS. READ THE LATEST NEWS BELOW THAT AFFECTS YOU.
According to a story in USA Today, a medical expert says researchers should take a closer look at the Type 2 diabetes medications Byetta and Januvia, after a study linked them to pancreatitis and pancreatic cancer.
Dr. Ronald Goldberg, professor of medicine, biochemistry and molecular biology at the University of Miami Miller School of Medicine, is quoted as saying: "I don't think the study is definitive, but it raises a flag and is clearly something we need to pay attention to going forward."
According to a story in the Boston Globe, the U.S. Food and Drug Administration reported more than 900 reports of problems with IVC filters, such as those manufactured by Bard, since 2005.
The story describes the filters as small devices with spidery metal legs, inserted inside a large abdominal vein to keep clots from traveling to the lungs.
The U.S. Food and Drug Administration is investigating whether the German company Fresenius Medical Care kept quiet about the possibility that one of its products could cause fatal heart attacks.
An article in the New York Times says Fresenius operates dialysis centers. In addition to treating more than a third of the estimated 400,000 Americans who receive dialysis, it is also the country's leading supplier of machines and disposable products used in the process.
The participating law firms are as follows: Anapol Schwartz (Philadelphia, Pennsylvania; Cherry Hill, New Jersey; Media, Pennsylvania; Reading, Pennsylvania; Wheeling, WV). J. F. Humphreys (Charleston, West Virginia). Lopez McHugh (Newport Beach, California; Philadelphia, PA; and Moorestown, NJ). Click here for more information about these law firms.
Some of our partner firms do not accept some types of cases. For details on these case exceptions, click here.
©2013 Legal View.com, LLC - All Rights Reserved | Home | Privacy Policy | Contact Us | Legal Issues | Web Design Company
Kadcyla: Drug Safety Communication - Potential Medication Errors Resulting from Name Confusion
The FDA notified health care professionals that the use of the incorrect nonproprietary name for the breast cancer drug Kadcyla (ado-trastuzumab emtansine) in some medication-related electronic systems poses a risk of mix-up with Herceptin (trastuzumab) and may result in medication errors. The dosing and treatment schedules for Kadcyla and Herceptin, another breast cancer drug, are quite different, so confusion between these products could lead to dosing errors and potential harm to patients.
It is important for drug information content publishers to identify drug products by the FDA-approved proprietary (brand) and nonproprietary names that are used in FDA-approved drug labels. This will help prevent medication errors and ensure adverse events are reported for the correct product.
TELL US ABOUT YOUR CASE